- Home
- GNS vs MNOV Comparison
GNS vs MNOV Comparison
Compare GNS & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNS
- MNOV
- Stock Information
- Founded
- GNS 2002
- MNOV 2000
- Country
- GNS Singapore
- MNOV United States
- Employees
- GNS N/A
- MNOV N/A
- Industry
- GNS Other Consumer Services
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- GNS Real Estate
- MNOV Health Care
- Exchange
- GNS Nasdaq
- MNOV Nasdaq
- Market Cap
- GNS 81.8M
- MNOV 65.7M
- IPO Year
- GNS 2022
- MNOV 2005
- Fundamental
- Price
- GNS $0.88
- MNOV $1.22
- Analyst Decision
- GNS
- MNOV Strong Buy
- Analyst Count
- GNS 0
- MNOV 2
- Target Price
- GNS N/A
- MNOV $7.00
- AVG Volume (30 Days)
- GNS 1.6M
- MNOV 26.2K
- Earning Date
- GNS 09-23-2025
- MNOV 11-12-2025
- Dividend Yield
- GNS N/A
- MNOV N/A
- EPS Growth
- GNS N/A
- MNOV N/A
- EPS
- GNS N/A
- MNOV N/A
- Revenue
- GNS $5,749,894.00
- MNOV $134,599.00
- Revenue This Year
- GNS $62.23
- MNOV N/A
- Revenue Next Year
- GNS $69.63
- MNOV N/A
- P/E Ratio
- GNS N/A
- MNOV N/A
- Revenue Growth
- GNS N/A
- MNOV N/A
- 52 Week Low
- GNS $0.21
- MNOV $1.13
- 52 Week High
- GNS $1.92
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- GNS 47.83
- MNOV 41.11
- Support Level
- GNS $0.79
- MNOV $1.23
- Resistance Level
- GNS $0.90
- MNOV $1.26
- Average True Range (ATR)
- GNS 0.08
- MNOV 0.03
- MACD
- GNS -0.00
- MNOV -0.00
- Stochastic Oscillator
- GNS 45.45
- MNOV 12.50
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education, which involves entrepreneur education, management consultancy, and business development tools; and Campus, consisting of resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America. The company derives maximum revenue from Europe/Middle East/Africa.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.